METHOTREXATE PHARMACOKINETICS IN PSORIATIC PATIENTS DEVELOPING HEPATIC-FIBROSIS

被引：13

作者：

JONES, SK

AHERNE, GW

CAMPBELL, MJ

WHITE, JE

机构：

[1] UNIV SURREY, DEPT BIOCHEM, GUILDFORD GU2 5XH, SURREY, ENGLAND

[2] SOUTHAMPTON GEN HOSP, DEPT COMMUNITY MED & MED STAT, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND

来源：

ARCHIVES OF DERMATOLOGY | 1986年 / 122卷 / 06期

关键词：

D O I：

10.1001/archderm.122.6.666

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

收藏

页码：666 / 669

页数：4

相关论文

共 17 条

[1] DEVELOPMENT AND APPLICATION OF A RADIOIMMUNOASSAY FOR METHOTREXATE
AHERNE, GW
PIALL, EM
MARKS, V
[J]. BRITISH JOURNAL OF CANCER, 1977, 36 (05) : 608 - 617
[2] COMPLICATIONS IN METHOTREXATE TREATMENT OF PSORIASIS WITH PARTICULAR REFERENCE TO LIVER FIBROSIS
ASHTON, RE
MILLWARDSADLER, GH
WHITE, JE
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1982, 79 (04) : 229 - 232
[3] METHOTREXATE HEPATOTOXICITY IN PSORIASIS - COMPARISON OF DIFFERENT DOSE REGIMENS
DAHL, MGC
SCHEUER, PJ
GREGORY, MM
[J]. BRITISH MEDICAL JOURNAL, 1972, 1 (5801) : 654 - &
[4] DONEHOWER RC, 1979, CLIN PHARMACOL THER, V26, P63
[5] THERAPEUTIC SUPPRESSION OF TISSUE REACTIVITY .2. EFFECT OF AMINOPTERIN IN RHEUMATOID ARTHRITIS AND PSORIASIS
GUBNER, R
AUGUST, S
GINSBERG, V
[J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1951, 221 (02) : 176 - 182
[6] HENDERSON ES, 1965, CANCER RES, V25, P1018
[7] HUFFMAN DH, 1973, CLIN PHARMACOL THER, V14, P572
[8] 7-HYDROXYMETHOTREXATE AS A URINARY METABOLITE IN HUMAN SUBJECTS AND RHESUS-MONKEYS RECEIVING HIGH DOSE METHOTREXATE
JACOBS, SA
STOLLER, RG
CHABNER, BA
JOHNS, DG
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1976, 57 (02) : 534 - 538
[9] CIRRHOSIS CAUSED BY METHOTREXATE IN TREATMENT OF PSORIASIS
MULLER, SA
FARROW, GM
MARTALOCK, DL
[J]. ARCHIVES OF DERMATOLOGY, 1969, 100 (05) : 523 - +
[10] ASSAY OF THERAPEUTIC DOSES OF METHOTREXATE IN BODY-FLUIDS OF PATIENTS WITH PSORIASIS
NOBLE, WC
PATH, MRC
WHITE, PM
BAKER, H
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1975, 64 (02) : 69 - 76